Press Release 24 September 2021

Eurazeo Completes Its Investment In Novair

The Paris Private Equity team advised Novair, a French specialist in on-site medical and industrial gas production solutions, on the acquisition of a minority stake in the group by Nov Santé Action Non Cotées, the fund managed by Eurazeo. The founder Bernard Zenou and his family remain the majority stakeholders.

Founded in 1977 by Bernard Zenou and based since then in the Paris region, Novair designs and builds solutions for the on-siteproduction of medical and industrial gases such as oxygen and nitrogen, which it exports around the world to serve its customers in the healthcare and manufacturing sectors. With subsidiaries in France and Italy, Novair masters all on-site medical and industrial gas production technologies.

The €26 M will enable Novair to pursue their ambitious expansion plans to disrupt the medical oxygen market worldwide.

The Goodwin team was led by Partner Benjamin Garçon and included Pauline Louis on the corporate aspects.